Gene Editing

American Heart Association Launches Initiative to Improve Clinical Trial Access for Rare Heart Condition

American Heart Association Launches Initiative to Improve Clinical Trial Access for Rare Heart Condition

The American Heart Association is addressing healthcare disparities by launching a comprehensive initiative to improve education, outreach, and access to clinical trials for transthyretin amyloid cardiomyopathy (ATTR-CM), focusing on underrepresented populations and emerging gene editing therapies.

May 27, 2025
Beam Therapeutics to Unveil Promising Sickle Cell Disease Treatment Data at European Hematology Congress

Beam Therapeutics to Unveil Promising Sickle Cell Disease Treatment Data at European Hematology Congress

Beam Therapeutics will present updated results from its BEACON trial for BEAM-101, an innovative ex vivo cell therapy targeting sickle cell disease, highlighting potential breakthrough treatment approaches at the European Hematology Association 2025 Congress.

May 23, 2025